نتایج جستجو برای: her 2

تعداد نتایج: 2593288  

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2006
Minghong Jiang Wenfang Shi Qi Zhang Xinhua Wang Minggao Guo Zhenfu Cui Changqin Su Qing Yang Yuemin Li Jonathan Sham Xinyuan Liu Mengchao Wu Qijun Qian

PURPOSE Therapeutic monoclonal antibody is increasingly applied in many clinical applications, although complicated technologies and high cost still limit their wide applications. To obtain the sustained serum antibody concentration with one single injection and lower the cost of antibody protein therapy, an adenovirus-mediated full-length antibody gene therapy was developed. EXPERIMENTAL DES...

Journal: :middle east journal of digestive diseases 0
l ahmadi s kamkari p mokarram k bagheri lankarani n tabibi h ashktorab

background gastric dysplasia (gd) is a precursor lesion of gastric adenoâ­carcinoma. intestinal type gastric carcinoma commonly shows microsatellite instability (msi) and the diffuse type is associâ­ated with down regulation of e-cadherin. her-2/neu is over-expressed in some cases of gastric cancer. in this study, msi and expression rates of her-2/neu and e-cadherin in gd were evaluated. me t h...

ژورنال: :مجله علمی دانشگاه علوم پزشکی گرگان 0
فرشاد نقش وار naghshvar f ساری، بلوار خزر، دانشکده پزشکی، گروه آسیب شناسی ژیلا ترابی زاده torabizadeh zh امید عمادیان emadian o امین زارع zare a مهران قهرمانی ghahremani m

زمینه و هدف: سرطان پستان شایع ترین سرطان در زنان می باشد. رشد و تمایز بافت طبیعی و بدخیم پستان به وسیله هورمون های استروئیدی و عوامل رشد از قبیل her-2/neu تنظیم می گردد. هدف از این مطالعه تعیین فراوانی بیان گیرنده استروژن، گیرنده پروژسترون و her-2/neu در یک جمعیت ایرانی مبتلا به سرطان پستان مهاجم بود.روش بررسی: این مطالعه به روش مقطعی- توصیفی روی 50 نمونه بیماران مبتلا به سرطان پستان مهاجم در ب...

Journal: :international journal of hematology-oncology and stem cell research 0
majid moghadaszadeh tabriz islamic azad university, tabriz, iran alireza nikanfar hematology and oncology department, tabriz university of medical sciences, tabriz, iran mohamadreza hemati tabriz islamic azad university, tabriz, iran behrouz gharib hematology- oncology and stem cell research center, shariati hospital, tehran university of medical sciences, tehran, iran sara sardashti hematology and oncology department, tabriz university of medical sciences, tabriz, iran

introduction: breast cancer is the most common malignancy with more than one million new cases diagnosed annually all around the world. its growth is mostly regulated by steroid hormones such as estrogen and peptide growth factors in interaction with epidermal growth factor 1 and 2. methods and materials: in this study, 237 patients who had consulted the oncology clinic of tabriz university of ...

2013
Shiuh-Wen Luoh Betsy Ramsey Amy Hanlon Newell Megan Troxell Zhi Hu Koei Chin Paul Spellman Susan Olson Edward Keenan

BACKGROUND Testing for human epidermal growth factor receptor-2 (HER-2) in breast cancer is performed by either immunohistochemistry (IHC) or in situ hybridization (ISH). The growth factor receptor-bound protein-7 (GRB7) gene is in close proximity to HER-2 on chromosome 17q11-12 and codes a signal transduction molecule shown to be an independent adverse marker in breast cancer. METHODS HER-2 ...

Journal: :The oncologist 2011
Naoki Hayashi Takayuki Iwamoto Ana M Gonzalez-Angulo Jaime Ferrer-Lozano Ana Lluch Naoki Niikura Chandra Bartholomeusz Seigo Nakamura Gabriel N Hortobagyi Naoto T Ueno

PURPOSE Tyrosine 1248 is one of the autophosphorylation sites of human epidermal growth factor receptor (HER)-2. We determined the prognostic value of the expression level of tyrosine 1248-phosphorylated HER-2 (pHER-2) in patients with HER-2(+) primary breast cancer using a reverse-phase protein array. PATIENTS AND METHODS The optimal cutoff value of pHER-2 for segregating disease-free surviv...

Journal: :Cancer research 2009
Olga Radkevich-Brown Jennifer Jacob Michael Kershaw Wei-Zen Wei

Genetic regulation of immune reactivity to Her-2 vaccination and the consequent antitumor effect was tested in human Her-2 transgenic (Tg) mice of C57BL/6 (B6), BALB/c (BALB), and (B6x BALB) F1 (F1) background. Mice were electrovaccinated with Her-2 DNA with or without pretreatment with CD25 monoclonal antibody to remove CD25(hi) regulatory T cells. When CD25(+) T cells were intact, BALB Her-2 ...

Journal: :Cancer research 2000
R T Reilly M B Gottlieb A M Ercolini J P Machiels C E Kane F I Okoye W J Muller K H Dixon E M Jaffee

HER-2/neu (neu-N) transgenic mice, which express the nontransforming rat proto-oncogene, develop spontaneous focal mammary adenocarcinomas beginning at 5-6 months of age. The development and histology of these tumors bears a striking resemblance to what is seen in patients with breast cancer. We have characterized the immunological responses to HER-2/neu (neu) in this animal model. neu-positive...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید